US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Celyad Oncology SA (0QFK) 銘柄情報

Celyad Oncology SA (0QFK)

18.94

0.00

(0.00%)

終了 6月13日 12:30AM

Celyad Oncology SA (0QFK) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

18.94

( - )

買値

18.47

売値

19.41

出来高

0.00

0.00 日の範囲 0.00

18.94 52 週間の範囲 18.94

時価総額

前日終値

18.94

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

15,753 €

発行済株式数

44,761,905

配当利回り

PER

16.61

1 株当たり利益 (EPS)

0.02

歳入

21k

純利益

830k

Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known a... Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. 詳細を表示

セクター

-

業界

-

ウェブサイト

celyad.com

本社

Mont-saint-guibert, Belgium

設立

2026

Celyad Oncology SA is listed in the sector of the ロンドン証券取引所 with ticker 0QFK. The last closing price for Celyad Oncology was 18.94 €. Over the last year, Celyad Oncology shares have traded in a share price range of 18.94 € to 18.94 €.

Celyad Oncology currently has 44,761,905 shares in issue. The market capitalisation of Celyad Oncology is 847.79 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of 16.61.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	18.94	18.94	18.94	1064	18.94	DE
52	0	0	18.94	18.94	18.94	635	18.94	DE
156	0	0	18.94	18.94	18.94	354	18.94	DE
260	0	0	18.94	18.94	18.94	856	18.94	DE

0QFK - Frequently Asked Questions (FAQ)

What is the current Celyad Oncology SA share price?

The current share price of Celyad Oncology SA is 18.94 €

How many Celyad Oncology SA shares are in issue?

Celyad Oncology SA has 44,761,905 shares in issue

What is the market cap of Celyad Oncology SA?

The market capitalisation of Celyad Oncology SA is EUR 847.79M

What is the 1 year trading range for Celyad Oncology SA share price?

Celyad Oncology SA has traded in the range of 18.94 € to 18.94 € during the past year

What is the PE ratio of Celyad Oncology SA?

The price to earnings ratio of Celyad Oncology SA is 16.61

What is the cash to sales ratio of Celyad Oncology SA?

The cash to sales ratio of Celyad Oncology SA is 637.32

What is the registered address of Celyad Oncology SA?

The registered address for Celyad Oncology SA is Axis Business Park, Mont-Saint-Guibert, Walloon Brabant, 1435

What is the Celyad Oncology SA website address?

The website address for Celyad Oncology SA is celyad.com

grantastic

grantastic 8分前

At least the dilution stopped!

jour_trader

jour_trader 18分前

Look up a company that just had its IPO, Apotex (APTX). This site says cash flow value is $62.18 (same metric you are using for Elite’s $2.55). The IPO price was about $24. I don’t think the calculation for this metric is reliable or even close. For an IPO you are maximizing share price as the compa

skitahoe

skitahoe 20分前

Forget about the FDA for just a bit, once we have a cleanroom approved with EDEN's, then ask.
Actually, at that point you can also ask about Europe, Canada, Australia, etc. as they'll all potentially be targets for approvals.

I don't know how the company intends to build, numer

csuck555

csuck555 26分前

I might need a little help to get this to the finish line. Just give me .29 so I can start reloading and then I will let it boom. It can’t be just me playing chicken with my shares. I take the risk while someone scoops in and buys the cheapies. Not fair.

THEBEASTMUGABI

THEBEASTMUGABI 27分前

BORING !! Come on guys, what’s going on? Announce something !

csuck555

csuck555 34分前

Who’s going to help me get this to .20s next week! Let’s go!Big walls ‘a comin

surfer44

surfer44 38分前

2026 10th Capital Link Maritime Leaders Summit – Greece | Navigating the Market

https://youtu.be/CiPXZ7_tVJc

raiderz

raiderz 44分前

Wrong. 1/29/26 I’m on record:

“I’m happy to finally free up some cash and still hold a bag.”

Which is still true.

The part I embellished: price was .008 not .0085 🫡

janice shell

janice shell 48分前

If the system just "created" a new profile for her, then why does it say the profile was created back in 2025?

Because IHub hasn't yet updated that. Go to the Message List page and scroll up to "Search this Board". You'll see that the last year available for a search is 2025. But in r

chereb19

chereb19 52分前

You keep repeating "negative margins" as if businesses never improve economics over time. The awkward part is ignoring the obvious operational changes that affect cost structure.

The logic here seems to be: "it wasn't profitable before, therefore it can never be profitable." That's no

grantastic

grantastic 53分前

Supposedly HDUP acquired this "LotteryHUB" in May 2022, according to their disclosure. However:

1. HDUP still listing as "acquired in the last 12 months" even as of April 2026
2. Nothing on the website "lotteryhub.com" indicates any connection to: HDUP, Mark Hutchison, Kelly

Split T

Split T 1時間前

Musk has literally guaranteed his employees a very handsome and maximum return with no chance of the stock cratering before they all dispose of what they wish to sell. SMART MOVE FOR HIM AND HIS EMPLOYEE'S . IMO they will be able to buy back in when it tanks for the first time. IT is not worth th

81vette

81vette 1時間前

I understand now,merger was complete but had a 20 day mandatory conversion waiting period from filing date ,it ended Wednesday and merger was complete and new company’s first day was Thursday,Friday was 1st day of some institutional buying (burst basket trades) Monday could be really good with insti

RockQQ

RockQQ 1時間前

Wow, we always suspected! Good link!

RockQQ

midastouch017

midastouch017 1時間前

I came to the sad conclusion that discussing
RDHL is a sheer waste of time!
:-(

MartinLutherKing

MartinLutherKing 1時間前

The short song and dance is over rockafella, You just can’t get em cheapies so easily.. You got to pay to play in the big leagues

janice shell

janice shell 1時間前

Oh yes, I remember. It's a pretty color. And they're very useful.

I may not be able to resist. It really IS a fabulous value. The reviewers seem to like it.

surfer44

surfer44 2時間前

2026 10th Capital Link Maritime Leaders Summit – Greece | Dry Bulk at an Inflection Point

https://youtu.be/adh3JnRr8qo

Whalatane

Whalatane 2時間前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 2時間前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 2時間前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 2時間前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 2時間前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

mmayr 2時間前

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 2時間前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

Celyad Oncology

Nanostring Technologies

Rep Fse 06 38 O A T

BNP Paribas Issuance

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。